Differential Ligand-Mediated Pituitary Somatostatin Receptor Subtype Signaling: Implications for Corticotroph Tumor Therapy

Endocr Rev. 2009 Dec 1;30(7):933. doi: 10.1210/edrv.30.7.9983.
No abstract available